国药一致

- 000028

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2026  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016 
国药一致(000028) 利润表
单位:万元
报表日期2026-03-312025-12-312025-09-302025-06-302025-03-31
一、营业总收入1,782,340.987,341,585.845,512,449.073,679,659.841,829,351.94
营业收入1,782,340.987,341,585.845,512,449.073,679,659.841,829,351.94
二、营业总成本1,743,213.657,181,283.045,387,458.953,595,591.871,788,147.32
营业成本1,604,835.536,557,539.144,934,455.223,286,481.171,640,111.43
营业税金及附加4,644.9418,630.8513,888.649,337.134,470.52
销售费用106,207.69484,691.60355,125.61243,628.12117,073.04
管理费用23,943.24100,126.7470,340.3646,664.4322,074.75
财务费用3,430.9118,296.0311,993.138,317.853,825.33
研发费用151.331,998.691,655.981,163.16592.26
资产减值损失----------
公允价值变动收益--312.88322.95----
投资收益5,798.3021,760.7416,507.4113,612.647,951.89
其中:对联营企业和合营企业的投资收益7,013.0431,568.3622,817.5417,997.0510,021.29
汇兑收益----------
三、营业利润37,658.69151,282.88133,347.7692,649.6543,913.82
加:营业外收入269.942,008.461,351.251,019.27656.80
减:营业外支出242.582,389.312,933.521,857.58737.93
其中:非流动资产处置损失----------
四、利润总额37,686.05150,902.03131,765.4891,811.3343,832.69
减:所得税费用7,169.9638,067.1729,825.7520,551.959,064.96
五、净利润30,516.10112,834.87101,939.7471,259.3834,767.73
归属于母公司所有者的净利润28,746.25113,592.6895,711.8566,590.7332,799.85
少数股东损益1,769.85-757.826,227.894,668.651,967.88
六、每股收益
基本每股收益(元/股)0.52002.04001.72001.20000.5900
稀释每股收益(元/股)0.52002.04001.72001.20000.5900
七、其他综合收益--197.05-3.63-3.63--
八、综合收益总额30,516.10113,031.92101,936.1171,255.7534,767.73
归属于母公司所有者的综合收益总额28,746.25113,709.9395,708.2266,587.1132,799.85
归属于少数股东的综合收益总额1,769.85-678.016,227.894,668.651,967.88
下载全部历史数据到excel中 返回页顶